Skip to content

Group Schema Focused Therapy for Eating Disorders with Comorbid Personality Disorders

Group Schema Focused Therapy for Eating Disorders with Comorbid Personality Disorders - STEP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON56471
Enrollment
12
Registered
2024-02-21
Start date
2024-02-01
Completion date
Unknown
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eating disorders Personality disorders

Interventions

Thirty weekly sessions of 90 minutes of group SFT will be offered to participating patients. The therapy will be based upon the protocol described by Tjoa & Muste (2021), which in its turn is based

Sponsors

Parnassia Bavo Groep (Den Haag)
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - A co-morbid ED and PD diagnosis according to DSM-5 - Previous ED-treatment had not been sufficient in diminishing the symptoms of ED - Age 18-65 - Dutch as a first language (or estimated as sufficient to receive treatment in Dutch) - Willingness to participate in the study (signed informed consent)

Exclusion criteria

Exclusion criteria: Current PD treatment

Design outcomes

Primary

MeasureTime frame
The main study parameter is change in the severity of ED symptoms in the baseline phase compared to the intervention phase on the one hand and change in the manifestation and severity of dysfunctional core beliefs on the other hand. This will be measured via: 1. The short form of the Eating Disorder Questionnaire (EDE-QS). This is a 12-item self-report questionnaire with good psychometric qualities (Gideon et al., 2016). 2. The idiosyncratic dysfunctional core beliefs formulated by patients (belief ratings will be expressed on a Visual Analogue Scale (VAS) ranging from 1 - 100).

Secondary

MeasureTime frame
Other parameters of interest in this study are quality of life, psychosocial functioning and the number of patients that drop out. These will be measured through the following instruments: 1. Mental Health Quality of Life Questionnaire (MHQoL). This is a self-report questionnaire with good psychometric qualities. 2. WHO Disability Assessment Schedule 2.0 (WHODAS): 36-item self-report version. This is an assessment instrument measuring problems with psychosocial functioning. It has good psychometric qualities (Üstün et al., 2010).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)